SeaSpine to Report Third Quarter 2022 Financial Results on November 1, 2022

Rhea-AI Summary

SeaSpine Holdings Corporation (NASDAQ: SPNE) will release its third quarter financial results on November 1, 2022, after market close. A conference call and webcast will follow at 1:30 pm PT / 4:30 pm ET, accessible via the company's website. SeaSpine specializes in surgical solutions for spinal disorders, offering innovative technologies like FLASH™ Navigation and a comprehensive range of spinal implants. The company operates in the U.S. and approximately 30 countries, focusing on meeting the evolving clinical needs of neurosurgeons and orthopedic spine surgeons.

Positive

• The company's innovative FLASH™ Navigation system enhances surgical accuracy and reduces operational costs.
• SeaSpine has a strategic focus on global market reach, with operations in the U.S. and around 30 countries.

Negative

• None.

CARLSBAD, Calif., Oct. 24, 2022 (GLOBE NEWSWIRE) -- SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced that it will release third quarter financial results after the close of trading on Tuesday, November 1, 2022. Members of the Company’s management team will host a corresponding conference call and webcast beginning at 1:30 pm PT / 4:30 pm ET.

To listen to the live webcast and a replay, please visit the Investors section of the SeaSpine website at: https://www.seaspine.com/.

About SeaSpine

SeaSpine (www.seaspine.com) is a global medical technology company focused on the design, development, and commercialization of surgical solutions for the treatment of patients suffering from spinal disorders. SeaSpine’s complete procedural solutions feature its market-leading FLASH™ Navigation, a system designed to improve accuracy of screw placement and provide a cost-effective, rapid, radiation-free solution to surgical navigation, and a comprehensive portfolio of spinal implants and orthobiologics to meet the varying combinations of products that neurosurgeons and orthopedic spine surgeons need to facilitate spinal fusion in degenerative, minimally invasive surgery (MIS), and complex spinal deformity procedures on the lumbar, thoracic and cervical spine. With product development expertise in advanced optics, software, orthobiologic sciences and spinal implants, SeaSpine can offer its surgeon customers a complete solution to meet their patients’ evolving clinical needs. SeaSpine currently markets its products in the United States and in approximately 30 countries worldwide.

Investor Relations Contact
Greg Chodaczek
ir@seaspine.com

FAQ

When will SeaSpine announce its Q3 financial results?

SeaSpine will announce its Q3 financial results on November 1, 2022, after market close.

What is the time for SeaSpine's conference call regarding the Q3 results?

The conference call will begin at 1:30 pm PT / 4:30 pm ET.

Where can I listen to SeaSpine's financial results webcast?

The webcast will be available in the Investors section of the SeaSpine website.

What type of products does SeaSpine offer?

SeaSpine offers surgical solutions for spinal disorders, including FLASH™ Navigation and a range of spinal implants.

In how many countries does SeaSpine market its products?

SeaSpine markets its products in approximately 30 countries worldwide.